Preliminary studies show conolidine may inhibit specific ion channels, minimizing neuronal excitability and restricting ache alerts. This system is especially suitable in neuropathic agony, where abnormal signaling triggers persistent pain. Additionally, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to ache percepti